NEW HAVEN, Conn. — August 29, 2025 — Leads & Copy — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company, announced that management will participate in fireside chats at the Wells Fargo Healthcare Conference on Thursday, September 4, and the Cantor Global Healthcare Conference on Friday, September 5.
Live audio webcasts of the presentations will be available on the Investors and Media section of the company’s website.
Arvinas is dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through its PROTAC protein degrader platform, pioneering the development of protein degradation therapies.
Arvinas is progressing multiple investigational drugs through clinical development programs, including vepdegestrant, ARV-393, ARV-102, and ARV-806.
Arvinas is headquartered in New Haven, Connecticut.
Contacts:
Investors: Jeff Boyle, +1 (347) 247-5089, Jeff.Boyle@arvinas.com
Media: Kirsten Owens, +1 (203) 584-0307, Kirsten.Owens@arvinas.com
